Literature DB >> 17195838

A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14.

Georg Bohn1, Anna Allroth, Gudrun Brandes, Jens Thiel, Erik Glocker, Alejandro A Schäffer, Chozhavendan Rathinam, Nicole Taub, David Teis, Cornelia Zeidler, Ricardo A Dewey, Robert Geffers, Jan Buer, Lukas A Huber, Karl Welte, Bodo Grimbacher, Christoph Klein.   

Abstract

Lysosome-related organelles have versatile functions, including protein and lipid degradation, signal transduction and protein secretion. The molecular elucidation of rare congenital diseases affecting endosomal-lysosomal biogenesis has given insights into physiological functions of the innate and adaptive immune system. Here, we describe a previously unknown human primary immunodeficiency disorder and provide evidence that the endosomal adaptor protein p14, previously characterized as confining mitogen-activated protein kinase (MAPK) signaling to late endosomes, is crucial for the function of neutrophils, B cells, cytotoxic T cells and melanocytes. Combining genetic linkage studies and transcriptional profiling analysis, we identified a homozygous point mutation in the 3' untranslated region (UTR) of p14 (also known as MAPBPIP), resulting in decreased protein expression. In p14-deficient cells, the distribution of late endosomes was severely perturbed, suggesting a previously unknown role for p14 in endosomal biogenesis. These findings have implications for understanding endosomal membrane dynamics, compartmentalization of cell signal cascades, and their role in immunity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17195838     DOI: 10.1038/nm1528

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  65 in total

Review 1.  mTOR in health and in sickness.

Authors:  Dritan Liko; Michael N Hall
Journal:  J Mol Med (Berl)       Date:  2015-09-22       Impact factor: 4.599

Review 2.  Genetic and molecular diagnosis of severe congenital neutropenia.

Authors:  Alister C Ward; David C Dale
Journal:  Curr Opin Hematol       Date:  2009-01       Impact factor: 3.284

3.  The novel lipid raft adaptor p18 controls endosome dynamics by anchoring the MEK-ERK pathway to late endosomes.

Authors:  Shigeyki Nada; Akihiro Hondo; Atsuko Kasai; Masato Koike; Kazunobu Saito; Yasuo Uchiyama; Masato Okada
Journal:  EMBO J       Date:  2009-01-29       Impact factor: 11.598

Review 4.  Disorders of lysosome-related organelle biogenesis: clinical and molecular genetics.

Authors:  Marjan Huizing; Amanda Helip-Wooley; Wendy Westbroek; Meral Gunay-Aygun; William A Gahl
Journal:  Annu Rev Genomics Hum Genet       Date:  2008       Impact factor: 8.929

Review 5.  Autophagosome formation in mammalian cells.

Authors:  Chloe Burman; Nicholas T Ktistakis
Journal:  Semin Immunopathol       Date:  2010-08-26       Impact factor: 9.623

6.  U1 snRNP-mediated poly(A) site suppression: beneficial and deleterious for mRNA fate.

Authors:  Jörg Langemeier; Maximilian Radtke; Jens Bohne
Journal:  RNA Biol       Date:  2013-01-16       Impact factor: 4.652

7.  Modified lentiviral LTRs allow Flp recombinase-mediated cassette exchange and in vivo tracing of "factor-free" induced pluripotent stem cells.

Authors:  Johannes Kuehle; Soeren Turan; Tobias Cantz; Dirk Hoffmann; Julia D Suerth; Tobias Maetzig; Daniela Zychlinski; Christoph Klein; Doris Steinemann; Christopher Baum; Juergen Bode; Axel Schambach
Journal:  Mol Ther       Date:  2014-01-17       Impact factor: 11.454

Review 8.  Genetic heterogeneity in severe congenital neutropenia: how many aberrant pathways can kill a neutrophil?

Authors:  Alejandro A Schäffer; Christoph Klein
Journal:  Curr Opin Allergy Clin Immunol       Date:  2007-12

Review 9.  Genetic insights into congenital neutropenia.

Authors:  Christoph Klein; Karl Welte
Journal:  Clin Rev Allergy Immunol       Date:  2010-02       Impact factor: 8.667

Review 10.  Multiple amino acid sensing inputs to mTORC1.

Authors:  Mitsugu Shimobayashi; Michael N Hall
Journal:  Cell Res       Date:  2015-12-11       Impact factor: 25.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.